These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16136990)

  • 1. [A 81-year-old case of latent autoimmune diabetes mellitus in adult].
    Wang TQ; Liu YS; Qu GY; Xiao X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):369. PubMed ID: 16136990
    [No Abstract]   [Full Text] [Related]  

  • 2. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus].
    Perusicová J; Bárová H; Hill M; Masek Z
    Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune diabetes in adults: lessons from the UKPDS.
    Desai M; Clark A
    Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes.
    Li X; Zhou ZG; Huang G; Yan X; Yang L; Chen XY; Wang JP
    Ann N Y Acad Sci; 2004 Dec; 1037():122-6. PubMed ID: 15699504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Latent autoimmune diabetes mellitus].
    St Martin
    Dtsch Med Wochenschr; 1999 Feb; 124(5):135. PubMed ID: 10076556
    [No Abstract]   [Full Text] [Related]  

  • 6. Single-tube test for autoantibodies to glutamic acid decarboxylase and proinsulin as first-line screening for autoimmunity in adult-onset diabetic patients.
    Valdez SN; Villalba A; Iacono RF; Poskus E
    Clin Immunol; 2004 Dec; 113(3):241-7. PubMed ID: 15507388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and immunochemical characterization of glutamic acid decarboxylase autoantibodies in patients with autoimmune diabetes mellitus.
    Villalba A; Iacono RF; Valdez SN; Poskus E
    Autoimmunity; 2008 Mar; 41(2):143-53. PubMed ID: 18324484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
    Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
    Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GAD antibodies in IDDM in Thailand.
    Rattarasarn C; Aguilar-Diosdado M; Soonthornpun S; Patarakijvanich N; Jaruratanasirikul S
    Diabetes Care; 1996 Jun; 19(6):674-5. PubMed ID: 8725876
    [No Abstract]   [Full Text] [Related]  

  • 10. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes.
    Castleden HA; Shields B; Bingley PJ; Williams AJ; Sampson M; Walker M; Gibson JM; McCarthy MI; Hitman GA; Levy JC; Hattersley AT; Vaidya B; Pearson ER
    Diabet Med; 2006 Aug; 23(8):834-8. PubMed ID: 16911619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults.
    Yang L; Zhou ZG; Tan SZ; Huang G; Jin P; Yan X; Li X; Peng H; Hagopian W
    Ann N Y Acad Sci; 2008 Dec; 1150():263-6. PubMed ID: 19120309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
    Amrouche Ch; Jamoussi Kamoun H; Trabelsi N; Blouza Chabchoub S
    Tunis Med; 2008 Apr; 86(4):316-8. PubMed ID: 19476130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to GAD in elderly patients with previously diagnosed NIDDM.
    Fukui M; Nakamura N; Nakano K; Sawada M; Aoji O; Obayashi H; Shigeta H; Kondo M
    Diabetes Care; 1998 Apr; 21(4):675-6. PubMed ID: 9571369
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical characteristics and classification of 2128 outpatients with diabetes].
    Qi HY; Zhou ZG; Li X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):184-6. PubMed ID: 16145908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical inquiries: What is the best way to distinguish type 1 and 2 diabetes?
    Crownover BK; Nashelsky J; Lo V
    J Fam Pract; 2005 Jul; 54(7):630-2; discussion 630. PubMed ID: 16009095
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate and its effect on the anti-GAD titre in two patients with rheumatoid arthritis and diabetes mellitus.
    van Deutekom AW; Nurmohamed MT; Peters MJ; van Eijk IC; Dijkmans BA; Hamann D; Heine RJ; Simsek S
    Ann Rheum Dis; 2008 Jul; 67(7):1051-2. PubMed ID: 18556448
    [No Abstract]   [Full Text] [Related]  

  • 17. GAD antibody in multiplex diabetic pedigrees of Chinese.
    Chen T; Ren Y; Long Y; Zhang X; Yu H; Tian H
    Diabetes Care; 2007 Dec; 30(12):3091-2. PubMed ID: 17878243
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroconversion of glutamic acid decarboxylase antibodies in a patient initially diagnosed as having type 2 diabetes mellitus.
    Nagai T; Imamura M; Mori M
    Intern Med; 2005 Apr; 44(4):299-302. PubMed ID: 15897639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAD antibodies in classification of Asian type 2 diabetes.
    Fukui M; Nakamura N; Kondo M
    Diabetes Care; 1999 Jun; 22(6):1011-2. PubMed ID: 10372266
    [No Abstract]   [Full Text] [Related]  

  • 20. [When and why should anti-GAD antibodies by looked for in the non-insulin-dependent diabetic patient?].
    Atlan-Gepner C; Vialettes B
    Diabetes Metab; 1999 Jun; 25(2):177-9. PubMed ID: 10443330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.